Ekso Bionics (EKSO)

• Market cap: $11.6M
• 1 day: -0.43%
• 5 days: 10.46%
• 1 month: -4.43%
• 3 months: -36.76%
• 6 months: -60.00%
• Year to date: -33.82%
• 1 year: -67.81%
• 5 years: -87.99%
• 10 years: -99.30%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

Employees: 66

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

14% more funds holding

Funds holding: 28 [Q3] → 32 (+4) [Q4]

6.44% less ownership

Funds ownership: 24.82% [Q3] → 18.37% (-6.44%) [Q4]

60% less capital invested

Capital invested by funds: $6.2M [Q3] → $2.47M (-$3.73M) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $1 143% upside
• Avg. target: $5 1,114% upside
• High target: $9 2,084% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Lake Street Ben Haynor 30% 1-year accuracy 3 / 10 met price target	143% upside $1	Buy Maintained	4 Mar 2025
HC Wainwright & Co. Swayampakula Ramakanth 23% 1-year accuracy 44 / 192 met price target	2,084% upside $9	Buy Reiterated	4 Mar 2025